Figure 3
From: Expression of the neuron-specific protein CHD5 is an independent marker of outcome in neuroblastoma
Expression of CHD5 protein is prognostic for neuroblastoma patients. Kaplan-Meier analysis documenting increased overall survival and event-free survival of neuroblastoma patients with tumors that have high CHD5 immunoreactivity versus patients with tumors that have low CHD5 expression, (A) overall survival (P < 0.001) and (B) event-free survival (P < 0.001). The analysis was performed with all 63 NB tumors, including all stages (stage 1, 2, 3, 4s and 4). Independent validation performed on 32 primary NB samples (C) overall survival (P = 0.001) and (D) event-free survival (P < 0.0001). DOD = dead of disease.